NFNegin Frounchi

Negin Frounchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Negin Frounchi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short interference RNAs in glomerulonephritis: A mini review

    by Negin Frounchi, Diana Jafari Nakhjavani, Sima Abediazar, MohammadReza Ardalan, Farahnoosh Farnood

    Glomerulonephritis (GN) is a heterogeneous group of kidney diseases characterized by inflammation and damage to the glomeruli. Current treatments for GN remain suboptimal, creating a pressing need for innovative therapeutic strategies. Short interfering RNAs (siRNAs) represent a promising advance in the therapeutic landscape for GN, offering targeted gene silencing that could fundamentally transform the management of this significant cause of kidney disease. siRNA therapies work by selectively silencing specific genes involved in the pathogenesis of GNs, including interferon pathways, B cell activation, TGF-β, MAPK1, HMGB1, BLYSS, and SIRT1. Preclinical evidence demonstrates improved kidney function and reduced glomerular damage in experimental models. While challenges remain in translating these findings to clinical applications, ongoing research suggests that siRNA-based therapies have the potential to transform the treatment of GN, offering new hope for patients with this challenging kidney disease. This review highlights the impact of siRNA-based therapies in GN, exploring their mechanisms, delivery systems, challenges, and preclinical and clinical evidence.

  • Kidney Replacement Therapy as a Rescue Strategy for Severe Acidosis in Diabetic Ketoacidosis: A Case Report

    by Vahideh Sadra, Masoud Nazemiyeh, Negin Frounchi, Farahnoosh Farnood

    Introduction: Diabetic ketoacidosis is a serious complication mainly affecting individuals with type 1 diabetes. It occurs due to insulin deficiency, leading to high blood glucose levels and ketone production, which causes metabolic acidosis. Treatment involves fluid resuscitation, insulin therapy, and correcting metabolic imbalances. Complications can arise from insulin resistance and acidosis. In severe cases of refractory metabolic acidosis, renal replacement therapy can improve outcomes by correcting potassium levels and aiding recovery. Methods: A 43‐year‐old Iranian woman with poorly controlled type 2 diabetes was admitted to Imam Reza Hospital with diabetic ketoacidosis. Despite initial treatment at a local health center, she required hemodialysis due to persistent severe metabolic acidosis. Findings: After hemodialysis and further treatment in the intensive care unit, her condition improved, and she was discharged on a multiple daily injection insulin regimen. The patient's presentation was complex, with hypokalemia being a rare finding in an initial diabetic ketoacidosis presentation. Discussion: The refractory hypokalemia was likely due to prolonged gastrointestinal losses from vomiting. The most significant error in management was the delay in initiating insulin infusion despite the diabetic ketoacidosis diagnosis. Renal replacement therapy was used as a salvage method to correct severe acidosis and potassium deficits, showing its potential effectiveness in such cases.


  • Open Access

    Xanthogranulomatous Endometritis in Pregnancy: A Rare Case Concurrent With High‐Grade Serous Ovarian Carcinoma

    by Behrooz Shokouhi Gogani, Negin Frounchi, Sadaf Parvin, Sepideh Hadimaleki

    Xanthogranulomatous endometritis (XGE), typically a postmenopausal condition, has been diagnosed for the first time in a pregnant woman. This case also demonstrates the first reported association of XGE with high‐grade serous ovarian carcinoma, underscoring the need for malignancy screening in XGE patients, regardless of pregnancy status. This highlights the importance of prompt histopathological sampling to prevent misdiagnosis.

  • High‐Intensity Focused Ultrasound in Treatment of Primary Breast Cancer: A Systematic Review and Meta‐Analysis

    by Sogol Alikarami, Hamid Harandi, Ali Jahanshahi, Seyed Sina Zakavi, Negin Frounchi, Mohammad Ghavam, Sara Momtazmanesh

    Background: In recent years, tumor management strategies have focused on less invasive methods, aiming to yield optimal efficacy while minimizing further complications and enhancing the overall outcome of patients. High‐intensity focused ultrasound (HIFU), a known thermal ablative technique, has shown promising results in breast cancer treatment. Therefore, we performed this systematic review and meta‐analysis to assess the clinical, histopathologic, immunologic, and radiologic outcomes of HIFU ablative therapy and its complications in patients with primary breast cancer. Methods: We searched PubMed and Scopus databases to identify the eligible articles. Data extraction was conducted by two independent authors. A random effects model was employed to pool the proportion of remaining tumor after HIFU therapy in breast cancer. A subgroup analysis was performed according to imaging guidance modality and study design. Moreover, the heterogeneity and bias were assessed using funnel plot, Egger's regression plot, and Baujat plot. Pooled CD4/CD8 ratio mean difference between HIFU and radical mastectomy was measured using a fixed‐effect model. Results: We included 26 studies and 677 participants in the systematic review. Tumor necrosis rates varied, with 4 studies reporting less than 50% complete necrosis and 5 more than 50%. Two studies observed HIFU‐induced disturbances in the microvasculature of the targeted tissue. Six noted no contrast enhancement in successfully treated areas, two observed a thin rim indicating necrosis or fibrosis, and four reported a persistent enhancement in MRI images associated with a residual viable tumor. The weighted proportion of patients with residual tumor was 0.59 (95% CI; 0.44–0.73). The subgroup analysis demonstrated that although the pooled proportion of ultrasound‐guided studies was notably higher than magnetic resonance imaging‐guided studies (0.71 vs. 0.57), the between‐group difference was not statistically significant ( p = 0.1693). The diagnostic tools showed that the results are driven by certain studies, and there is also a potential small‐study effect. Furthermore, the CD4/CD8 ratio was higher in the HIFU group, with a weighted mean difference of 0.6 (95% CI: 0.41–0.78). The most prevalent side effects were pain (47.14%) and skin burn (2.59%). Conclusions: HIFU is a relatively safe procedure for the treatment of breast cancer as an independent or conjugated therapy and its effectiveness is promising regarding histopathological response, immunological reactivity, and vascular damage in the targeted area.


  • Open Access

    Renal Epithelioid Angiomyolipoma: A Case Report

    by Bahareh Mehramouz, Negin Frounchi, Sepideh Hadimaleki, Parisa Mehrasa

    Angiomyolipoma (AML) is a rare benign mesenchymal tumor, constituting less than 10% of renal masses, and occurs sporadically or in association with tuberous sclerosis complex (TSC). AML is generally categorized into classic AML and epithelioid angiomyolipoma (EAML), with the latter comprising approximately 4.6% of AML cases. EAML is characterized by a predominance of epithelioid cells, minimal adipose tissue, and distinct histological features such as necrosis and potential malignancy, which can lead to misdiagnosis as renal cell carcinoma (RCC). This report presents a case of renal EAML in a 27‐year‐old Iranian woman with mild left flank pain and hematuria, with imaging studies revealing an echogenic mass in the left kidney suggestive of AML. Contrast‐enhanced computed tomography and magnetic resonance imaging confirmed a heterogeneous mass with fat content. Histopathological examination post‐partial nephrectomy revealed a carcinoma‐like lesion with a proliferation of epithelioid cells, necrosis, and scattered giant cells, consistent with EAML. Notably, the tumor exhibited low mitotic activity and lacked atypical mitoses, confirming its benign nature. Despite the rarity of EAML and the lack of distinct clinical or radiological features, this case underscores the importance of pathological findings for accurate diagnosis. The management of EAML remains challenging due to its aggressive potential; however, surgical intervention is often the gold standard treatment. This case contributes to the limited literature on EAML, emphasizing the need for further research to establish definitive diagnostic criteria and treatment guidelines to address its clinical uncertainties.


  • Open Access

    Investigating cognitive function in patients with end-stage kidney disease under hemodialysis or peritoneal dialysis; a cross-sectional study

    by Bahram Niknafs, Farahnoosh Farnood, Negin Khadem Haghighi, Seyyedeh Mina Hejazian, Negin Frounchi, Mohammadreza Ardalan

    Introduction: Studies have shown that patients with chronic kidney failure and patients under dialysis have a significantly augmented risk of developing cognitive damage compared to the general population. Objectives: The purpose of this study was to explore cognitive function in people with end-stage kidney disease (ESKD) under hemodialysis or peritoneal dialysis who were referred to the dialysis center of Imam Reza Hospital in 2024. Materials and Methods: This cross-sectional study included 200 patients (100 patients under hemodialysis and 100 patients under peritoneal dialysis). Through a standardized MMSE (mini-mental state examination) questionnaire, the cognitive function of the patients was examined and compared between the two groups. Results: In this study, all variables of cognitive function including awareness of time (P<0.001), awareness of place (P<0.001), recall (P<0.001), attention and calculation (P<0.001), drawing (P=0.003), and MMSE total score (P<0.001) were significantly higher in patients under peritoneal dialysis in compared to patients under hemodialysis. Conclusion: Cognitive function appears to be significantly better in patients with ESKD under peritoneal dialysis than in those under hemodialysis. Given the high prevalence of cognitive impairment and its association with adverse outcomes, routine cognitive screening and individualized management strategies should be considered, regardless of dialysis modality.

  • Open Access

    Can Gamma-glutamyl Transferase Predict Unhealthy Metabolic Phenotypes Among Healthcare Workers in Azar Cohort Study?

    by Mohammadhossein Somi, Seyed Sina Zakavi, Alireza Ostadrahimi, Negin Frounchi, Neda Gilani, Sarvin Sanaie, Elnaz Faramarzi

    Background: Although various studies have assessed the correlation between gamma-glutamyl transferase (GGT) and cardiometabolic risk factors in obesity, no research has differentiated among metabolically-healthy obese (MHO) and metabolically unhealthy obese (MUHO), metabolically-healthy lean (MHL), and metabolically-unhealthy lean (MUHL). Objectives: Accordingly, this study evaluated the correlation between GGT and cardiometabolic phenotypes among healthcare workers. Methods: In this study, there were anthropometric measurements as well as the measurements of fasting blood sugar (FBS), GGT, cholesterol, triglyceride (TG), high lipoprotein density (HDL), and blood pressure in 1458 healthcare workers enrolled in the Azar Cohort Study. Metabolic syndrome (MetS) was defined according to the National Cholesterol Education Program Adult Treatment Panel III (ATP III). Accordingly, the participants were divided into four cardiometabolic phenotypes. Results: In this cross-sectional study, there was a significant difference in the prevalence of cardiometabolic phenotypes regarding the GGT tertiles (P ≤ 0.001). The highest prevalence of MHO was observed in the third GGT tertile. The mean waist circumference, TG, FBS, HDL, and systolic and diastolic blood pressure levels increased in the MHO, MUHO, and MHL groups in a dose dependent manner with an increase in the GGT tertiles (P < 0.05). In comparing the highest and lowest GGT tertile, the risk of MHO and MUHO increased by 2.84 (95%CI 2.01 - 4.01) and 9.12 (95%CI 5.54 - 15), respectively. However, the correlation between the GGT tertile and MUHL did not reveal a similar trend. The ROC curve shows the cutoff value of 18.5 U/L for GGT, which allowed us to distinguish between the MUHO and MHO individuals. Conclusions: The findings revealed that GGT can indicate the risk of MetS as such, it can be used to detect at-risk MHO individuals and administer proper interventions.